ISSCR News
The Future: Engagement, Translation, Access
During the course of my presidency, I will focus on the translation of science into medicine. Specifically, I will work to ensure the society expands our global engagement with clinicians and regulatory agencies to bring proven stem cell therapies to the patients who need them — and ensure that our physician colleagues have the tools and knowledge to actualize these therapies.
Member Spotlight: Pengyi Yang, PhD
I am excited to make an impact on translating the knowledge discovered from my computational models for stem cell-based therapies and regenerative medicine.
Amander T. Clark Takes on New Role as President of the ISSCR
The ISSCR is pleased to announce Amander T. Clark, PhD, Professor of Molecular, Cell and Developmental Biology, University of California, Los Angeles (UCLA), USA, as its President. Dr. Clark’s one-year term of office leading the global society begins 1 July 2023.
The ISSCR Statement on New Research with Embryo Models
The ISSCR supports research with embryo models derived from human pluripotent stem cells that is conducted with scientific and ethical rigor. ISSCR encourages researchers to continue to follow the ISSCR Guidelines for Stem Cell Research and Clinical Translation when considering research in this emerging area. Recent work presented at the ISSCR 2023 Annual Meeting in Boston, USA this month and additional research posted online as preprints shortly thereafter highlights the rapid pace of progress in the development of stem cell-based embryo models. To aid public understanding of this progress and assist the media in accurate reporting, the ISSCR provides the following information.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .